The PI3K Signaling Pathway As a Pharmacological Target in Autism Related Disorders and Schizophrenia

Overview

Journal Mol Cell Ther

Specialty Biochemistry

Date 2016 Feb 16

PMID 26877878

Citations 34

Authors

Lilian Enriquez-Barreto

Miguel Morales

Affiliations

Soon will be listed here.

Abstract

This review is focused in PI3K's involvement in two widespread mental disorders: Autism and Schizophrenia. A large body of evidence points to synaptic dysfunction as a cause of these diseases, either during the initial phases of brain synaptic circuit's development or later modulating synaptic function and plasticity. Autism related disorders and Schizophrenia are complex genetic conditions in which the identification of gene markers has proved difficult, although the existence of single-gene mutations with a high prevalence in both diseases offers insight into the role of the PI3K signaling pathway. In the brain, components of the PI3K pathway regulate synaptic formation and plasticity; thus, disruption of this pathway leads to synapse dysfunction and pathological behaviors. Here, we recapitulate recent evidences that demonstrate the imbalance of several PI3K elements as leading causes of Autism and Schizophrenia, together with the plausible new pharmacological paths targeting this signaling pathway.

Citing Articles

Developmental deficits, synapse and dendritic abnormalities in a Clcn4 KO autism mice model: endophenotypic target for ASD.

Lee S, Choi Y, Kim D, Jeong H, Do Y, Jung S Transl Psychiatry. 2025; 15(1):28.

PMID: 39863599 PMC: 11762770. DOI: 10.1038/s41398-024-03201-6.

Plasma microRNAs Associate Positive, Negative, and Cognitive Symptoms with Inflammation in Schizophrenia.

Miyano T, Hirouchi M, Yoshimura N, Hattori K, Mikkaichi T, Kiyosawa N Int J Mol Sci. 2025; 25(24.

PMID: 39769285 PMC: 11676741. DOI: 10.3390/ijms252413522.

Ex vivo disease modelling of Rett syndrome: the transcriptomic and metabolomic implications of direct neuronal conversion.

Karaosmanoglu B, Imren G, Ozisin M, Recber T, Simsek Kiper P, Haliloglu G Mol Biol Rep. 2024; 51(1):979.

PMID: 39269588 DOI: 10.1007/s11033-024-09915-6.

Maternal choline supplementation modulates cognition and induces anti-inflammatory signaling in the prefrontal cortices of adolescent rats exposed to maternal immune activation.

King C, Plakke B Brain Behav Immun Health. 2024; 40:100836.

PMID: 39206430 PMC: 11350509. DOI: 10.1016/j.bbih.2024.100836.

Copy number variations in autistic children.

Alhazmi S, Alharthi M, Alzahrani M, Alrofaidi A, Basingab F, Almuhammadi A Biomed Rep. 2024; 21(1):107.

PMID: 38868529 PMC: 11168027. DOI: 10.3892/br.2024.1795.

References

Caren H, Fransson S, Ejeskar K, Kogner P, Martinsson T . Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours. Br J Cancer. 2007; 97(10):1416-24. PMC: 2360241. DOI: 10.1038/sj.bjc.6604032. View

Chang Q, Khare G, Dani V, Nelson S, Jaenisch R . The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron. 2006; 49(3):341-8. DOI: 10.1016/j.neuron.2005.12.027. View

Kolbeck R, Bartke I, Eberle W, Barde Y . Brain-derived neurotrophic factor levels in the nervous system of wild-type and neurotrophin gene mutant mice. J Neurochem. 1999; 72(5):1930-8. DOI: 10.1046/j.1471-4159.1999.0721930.x. View

Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B . The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol. 2010; 11(5):329-41. DOI: 10.1038/nrm2882. View

Kim H, Kishikawa S, Higgins A, Seong I, Donovan D, Shen Y . Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet. 2008; 82(1):199-207. PMC: 2253961. DOI: 10.1016/j.ajhg.2007.09.011. View

Lonze B, Ginty D . Function and regulation of CREB family transcription factors in the nervous system. Neuron. 2002; 35(4):605-23. DOI: 10.1016/s0896-6273(02)00828-0. View

Tropea D, Giacometti E, Wilson N, Beard C, McCurry C, Fu D . Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci U S A. 2009; 106(6):2029-34. PMC: 2644158. DOI: 10.1073/pnas.0812394106. View

Karam C, Ballon J, Bivens N, Freyberg Z, Girgis R, Lizardi-Ortiz J . Signaling pathways in schizophrenia: emerging targets and therapeutic strategies. Trends Pharmacol Sci. 2010; 31(8):381-90. PMC: 3635536. DOI: 10.1016/j.tips.2010.05.004. View

Kalkman H . The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia. Pharmacol Ther. 2006; 110(1):117-34. DOI: 10.1016/j.pharmthera.2005.10.014. View

10.

Enriquez-Barreto L, Cuesto G, Dominguez-Iturza N, Gavilan E, Ruano D, Sandi C . Learning improvement after PI3K activation correlates with de novo formation of functional small spines. Front Mol Neurosci. 2014; 6:54. PMC: 3877779. DOI: 10.3389/fnmol.2013.00054. View

11.

Bourgeron T . A synaptic trek to autism. Curr Opin Neurobiol. 2009; 19(2):231-4. DOI: 10.1016/j.conb.2009.06.003. View

12.

Ostendorf A, Gutmann D, Weisenberg J . Epilepsy in individuals with neurofibromatosis type 1. Epilepsia. 2013; 54(10):1810-4. DOI: 10.1111/epi.12348. View

13.

Poduri A, Evrony G, Cai X, Elhosary P, Beroukhim R, Lehtinen M . Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron. 2012; 74(1):41-8. PMC: 3460551. DOI: 10.1016/j.neuron.2012.03.010. View

14.

Zhang J, Hou L, Klann E, Nelson D . Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models. J Neurophysiol. 2009; 101(5):2572-80. PMC: 2681424. DOI: 10.1152/jn.90558.2008. View

15.

Thiselton D, Vladimirov V, Kuo P, McClay J, Wormley B, Fanous A . AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families. Biol Psychiatry. 2007; 63(5):449-57. PMC: 2441648. DOI: 10.1016/j.biopsych.2007.06.005. View

16.

Heaton P, Wallace G . Annotation: the savant syndrome. J Child Psychol Psychiatry. 2004; 45(5):899-911. DOI: 10.1111/j.1469-7610.2004.t01-1-00284.x. View

17.

Kwiatkowski D, Manning B . Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet. 2005; 14 Spec No. 2:R251-8. DOI: 10.1093/hmg/ddi260. View

18.

Jansen L, Mirzaa G, Ishak G, ORoak B, Hiatt J, Roden W . PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia. Brain. 2015; 138(Pt 6):1613-28. PMC: 4614119. DOI: 10.1093/brain/awv045. View

19.

Harris L, Guest P, Wayland M, Umrania Y, Krishnamurthy D, Rahmoune H . Schizophrenia: metabolic aspects of aetiology, diagnosis and future treatment strategies. Psychoneuroendocrinology. 2012; 38(6):752-66. DOI: 10.1016/j.psyneuen.2012.09.009. View

20.

Basu T, Gutmann D, Fletcher J, Glover T, Collins F, Downward J . Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature. 1992; 356(6371):713-5. DOI: 10.1038/356713a0. View